ALUROTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
ALLURION TECHNOLOGIES, INC.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 15, 2026
$0.47+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $6.34M
- P/E (TTM)
- –
- Dividend yield
- –
ALLURION TECHNOLOGIES, INC. revenue by segment
By business segment
By product or service
By region
| Revenue | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | Q2 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Other Countries | $1.71M | $2.84M | $941.00K | $1.88M | $3.45M | $6.68M | $2.66M | $8.45M | $5.35M | $6.94M | $11.12M | $10.81M | 58.1% | -50.4% |
| Italy | $572.00K | $639.00K | $418.00K | $436.00K | $348.00K | $443.00K | $511.00K | $887.00K | – | – | $626.00K | – | 19.4% | +64.4% |
| Spain | $380.00K | $337.00K | $282.00K | $786.00K | $749.00K | $1.01M | $439.00K | $1.45M | $1.11M | $903.00K | $1.20M | $896.00K | 12.9% | -49.3% |
| Chile | $283.00K | – | $271.00K | – | $432.00K | – | – | – | – | – | $1.96M | – | 9.6% | -34.5% |
| United States | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | – | 0.0% | – |
| Egypt | $0 | – | $450.00K | – | $600.00K | – | – | – | $0 | – | – | – | 0.0% | -100.0% |
| France | – | – | – | $274.00K | $0 | $59.00K | – | $1.87M | $1.67M | $1.15M | $1.31M | $1.26M | – | – |
| United Kingdom | – | – | $66.00K | $56.00K | $81.00K | – | $361.00K | $917.00K | $1.26M | – | $1.20M | $1.06M | – | – |
| TRY | – | – | – | – | – | $0 | $966.00K | – | – | – | $3.52M | – | – | – |
| Australia | – | – | $24.00K | – | – | – | $543.00K | – | – | – | $979.00K | – | – | – |
| Argentina | – | – | $272.00K | – | – | – | $247.00K | – | – | – | – | – | – | – |
From the segment and revenue-disaggregation notes of Allurion Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.